The Analyst Verdict: Roivant Sciences In The Eyes Of 6 Experts
The Analyst Verdict: Roivant Sciences In The Eyes Of 6 Experts
分析師的判決：6位專家眼中的Roivant Sciences
6 analysts have shared their evaluations of Roivant Sciences (NASDAQ:ROIV) during the recent three months, expressing a mix of bullish and bearish perspectives.
最近三個月來，有6位分析師分享了他們對Roivant Sciences（納斯達克股票代碼：ROIV）的評估，表達了看漲和看跌的觀點。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表總結了他們最近的評估，說明了過去30天不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Roivant Sciences, revealing an average target of $18.33, a high estimate of $23.00, and a low estimate of $15.00. Observing a 12.8% increase, the current average has risen from the previous average price target of $16.25.
分析師爲Roivant Sciences設定了12個月的目標股價，顯示平均目標股價爲18.33美元，最高估計爲23.00美元，低估值爲15.00美元。目前的平均價格上漲了12.8％，已從之前的平均目標價16.25美元上漲。
Investigating Analyst Ratings: An Elaborate Study
調查分析師評級：一項詳盡的研究
A comprehensive examination of how financial experts perceive Roivant Sciences is...
對金融專家如何看待Ro...
登入免費觀看全文
登入/註冊